Newsroom
October Newsletter
View Original Highlights International Summit on Chemical Reactions and [...]
September Newsletter
View Original Highlights Successful Opening Ceremony of Asymchem and [...]
Asymchem and LaNova Medicines Enter into Partnership Agreement, Expanding Biological Capabilities
Read Release Here SHANGHAI, P.R. China, Sept 16, 2021: [...]
August Newsletter
View Original Highlights Asymchem CEO Listed Among Top 50 [...]
Expansion Plans Announced
Parallel Manufacturing This year, Asymchem began construction on two new […]
July Newsletter
View Original Highlights Technology-driven, detail-oriented and efficient: Asymchem celebrates two [...]
Asymchem establishes centers focused on novel manufacturing technologies, including continuous flow
Asymchem establishes a Center of Flow & Continuous Technology [...]
June Newsletter
View Original Highlights Asymchem 2020 Shareholder Annual Meeting May [...]
May Newsletter
View Original Highlights Asymchem Released 2020 Annual Report April [...]
April Newsletter
View Original Highlights Inauguration ceremony of Asymchem “Center of Biosynthesis [...]
Asymchem Expands Manufacturing Capacity for Oligonucleotides
Read Release Here TEDA TIANJIN, P.R. China, March 25, [...]
March Newsletter
View Original Highlights Asymchem’s Zhenjiang R&D and production site [...]
Asymchem Opens Center Dedicated to Biosynthetic Technology R&D
TEDA TIANJIN, P.R. China, March 9, 2020 – Asymchem [...]
ARTICLE: Ketoreductase/Transaminase, One-Pot, Multikilogram Biocatalytic Cascade Reaction
Asymchem co-authors an article published in Organic Process Research [...]
January Newsletter
View Original Highlights Asymchem Attends the 20th CPhI China The [...]
Electroreductive Olefin–Ketone Coupling
Asymchem co-authors article published in OPRD titled, "Electroreductive Olefin–Ketone [...]
Development and Proof of Concept for a Large-Scale Photoredox Additive-Free Minisci Reaction
Asymchem co-authors article published in OPRD titled, "Development and [...]
Development and Scale-Up of an Improved Manufacturing Route to the ATR Inhibitor Ceralasertib
Asymchem co-authors article published in OPRD titled, "Development and [...]
December Newsletter
View Original Highlights Dr. Hao Hong, Chairman and CEO [...]
November Newsletter
View Original Highlights Asymchem was awarded as “Top 100 Comprehensive [...]
October Newsletter
View Original News Highlights Asymchem Plans to Establish A Wholly-owned Subsidiary [...]
September Newsletter
News Highlights Asymchem and Snapdragon Chemistry Sign Partnership Agreement [...]
Asymchem and Snapdragon Enter Investment Partnership
TEDA TIANJIN, P.R. China, Sept 02, 2020 – Asymchem, [...]
August Newsletter
News Highlights 2020 Asymchem School Recruiting Welcome Event Held [...]
Asymchem Constructs R&D Innovative Platform for PDC Drugs
Antibody-Drug Conjugates (ADCs) are known as a "biological missile". [...]
Asymchem’s co-publication in “Org. Process Res. Dev.”- “Development and Execution of a Production- Scale Continuous [2+2] Photocycloaddition”
Recently, Asymchem (stock code: 002821.SZ) co-published a paper with [...]
June Newsletter
On June 2, Dr. Hong and other company leaders visited Zhenjiang Economic Development Area [...]
Asymchem’s 2019 Annual Report At a Glance
Click here to download the presentation.
Asymchem Assures Business Continuity Amid the COVID-19 Outbreak
TEDA TIANJIN, China, Feb. 24, 2020 /PRNewswire/ -- Asymchem announced today that [...]
Asymchem co-hosted with the American Chemical Society (ACS) the first Asian Green Chemistry Institute Roundtable
September 18-19, 2019, Asymchem co-hosted the ACS GCI Pharmaceutical [...]
How business school helped Asymchem CEO Hao Hong take a bold step
An executive education programme crystalised the founder’s ideas for a new direction
